A team of researchers at the University of Texas Medical Branch has found a modest link between the use of IV bisphosponates and atrial fibrillation and strokes. After examining around 20,000 patients (6,857 of which were on bisphosphonate therapy) they determined there was an increased chance of having these disorders. The FDA had previously investigated a link between a-fib and bisphosphonates.
Bisphosphonates include Fosamax, Fosamax-D, Boniva, Reclast, Aredia, Actonel, Zometa and others. These drugs recently received a classwide label change to include warning about a certain kind of femur fracture.
If you have been injured from taking Fosamax or another bisphosphonate contact an attorney at Rheingold, Giuffra, Ruffo & Plotkin LLP for a free consultation.